IDEXX Laboratories Inc

Healthcare · Diagnostics & Research

518.40$ +0.1% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Income Statement

IDEXX Laboratories Inc (IDXX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 1,217 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement IDXX
Line item	Q3 16	Q4 16	Q1 17	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	LTM
Revenue	448	443	462	509	492	506	538	581	545	549	576	620	605	605	626	638	722	721	778	826	810	801	837	861	842	829	900	944	916	902	964	1,004	976	954	998	1,109	1,105	1,091	1,141	1,217	4,553
Cost of Revenue	202	202	204	216	218	234	235	248	240	249	244	262	260	274	267	258	299	311	307	337	338	345	338	347	335	344	357	371	368	375	371	383	380	384	375	415	422	432	418	437	1,710
Gross Profit	247	241	258	293	274	272	303	332	306	300	332	358	345	331	360	379	423	410	471	489	473	456	499	514	507	485	543	573	548	526	593	621	596	571	623	695	683	658	723	779	2,843
Research & Development	26	25	26	27	28	29	29	30	29	30	32	32	34	35	33	32	38	39	38	38	40	45	40	123	48	43	45	47	48	52	53	55	54	58	59	62	63	67	66	65	261
Selling, General & Administrative	53	51	53	55	57	55	61	61	64	59	60	60	66	75	66	60	105	70	71	73	82	83	78	81	84	83	70	90	89	87	92	157	92	101	92	99	106	109	119	117	450
Total Operating Expenses	158	157	166	170	174	175	190	187	188	185	198	194	205	216	215	186	251	224	223	230	247	257	250	335	262	258	263	277	273	281	294	355	292	309	307	322	329	343	360	354	1,385
Operating Income	88	84	92	123	100	98	113	146	117	115	133	164	140	116	144	193	172	185	248	259	226	199	248	179	245	227	280	296	275	245	299	264	304	262	317	373	355	316	363	426	1,459
Interest Expense	7.8	7.8	8.6	9.2	9.8	9.7	9.3	8.5	8.5	8.6	8.4	8.2	7.1	7.4	7.7	9.5	8.1	7.8	7.6	7.6	7.1	7.5	7.0	8.3	11	14	13	11	8.6	9.3	7.9	8.1	7.7	7.5	7.7	11	11	11	7.7	10	39
Pre-Tax Income	82	77	85	115	92	90	104	137	109	107	125	156	133	109	137	184	164	177	240	252	219	192	241	171	234	213	268	286	268	240	295	259	299	256	310	362	345	307	355	417	1,424
Income Tax Expense	25	25	16	29	22	51	15	29	16	21	22	30	24	18	25	35	18	2.5	36	49	44	29	48	39	53	41	54	62	56	45	60	56	66	40	67	68	70	59	77	79	285
Net Income	56	52	69	85	71	38	89	109	93	86	103	126	109	90	112	149	146	175	204	203	175	163	194	132	181	172	214	224	212	195	236	203	233	216	243	294	275	248	278	338	1,140
EBITDA	109	105	114	144	123	121	134	167	138	136	155	187	163	138	168	218	197	211	273	285	253	228	276	208	274	256	309	325	306	279	335	301	342	299	352	409	392	356	401	468	1,618

LTM = last twelve months (sum of the four most recent quarters).

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Income Statement

Cookie settings